e-learning
resources
London 2016
Sunday, 04.09.2016
Clinical aspects of ILD
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
The association between functional and HRQOL (K-BILD) outcome measures in IPF and other fibrotic ILDs
Charles Sharp (Bristol, United Kingdom), Charles Sharp, Christina Baggott, Heather Lamb, Surinder Birring, Huzaifa Adamali
Source:
International Congress 2016 – Clinical aspects of ILD
Session:
Clinical aspects of ILD
Session type:
Thematic Poster
Number:
805
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
Charles Sharp (Bristol, United Kingdom), Charles Sharp, Christina Baggott, Heather Lamb, Surinder Birring, Huzaifa Adamali. The association between functional and HRQOL (K-BILD) outcome measures in IPF and other fibrotic ILDs. Eur Respir J 2016; 48: Suppl. 60, 805
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Panel discussion: ANCA associated vasculitis and lung disease
Panel discussion on genetics in pulmonary fibrosis
The Relationship Between Functional Status and Fatigue After COVID-19 Infection
Related content which might interest you:
Do worse scores on patient-reported outcomes predict the progression of interstitial lung disease (ILD)?
Source: Virtual Congress 2021 – Interstitial lung disease around the world
Year: 2021
The King‘s brief interstitial lung disease quality of life questionnaire (K-BILD) for patients with IPF and other ILDs
Source: Annual Congress 2011 - Clinical approach of diffuse parenchymal lung disease
Year: 2011
Comparison of changes of the King’s brief interstitial lung disease questionnaire (K-BILD) with other health status measures
Source: International Congress 2016 – IPF: from pathogenesis to treatment I
Year: 2016
Psychological predictors of health-related quality of life of interstitial lung disease patients.
Source: International Congress 2019 – The changing face of rare diffuse parenchymal lung diseases: recent advances in pathogenesis, clinical manifestations and treatment
Year: 2019
Associations between measurements of health related quality of life (HRQoL) and physical activity (PA) in patients with interstitial lung disease (ILD)
Source: Annual Congress 2012 - Assessment of physical activity, exercise, muscle function and clinical characteristics as outcomes in physiotherapy and rehabilitation
Year: 2012
Correlation between the quality of life questionnaires and pulmonary lung functions in COPD patients
Source: Eur Respir J 2003; 22: Suppl. 45, 215s
Year: 2003
Item generation for a patient reported outcome measure (PRoM) in idiopathic pulmonary fibrosis (IPF): Application of consensus methods
Source: International Congress 2015 – IPF: clinical aspects
Year: 2015
Quality of life (HQoL) and well-being in patients with idiopathic pulmonary fibrosis (IPF): the role of portable oxygen
Source: Annual Congress 2008 - Management of idiopathic pulmonary fibrosis: what can we learn from the pathophysiology?
Year: 2008
A longitudinal study of anxiety and depression in idiopathic pulmonary fibrosis (IPF)
Source: Annual Congress 2013 –Diffuse pulmonary fibrosis
Year: 2013
Is there a relationship between quality of life and exercise performance in idiopathic pulmonary fibrosis (IPF)?
Source: Eur Respir J 2007; 30: Suppl. 51, 577s
Year: 2007
A comparison of heath-related quality of life in IPF and systemic sclerosis-related ILD
Source: International Congress 2019 – Assessment and management of immune-mediated interstitial lung diseases
Year: 2019
The relationship between GAP stage and quality of life in IPF and systemic sclerosis-related ILD is diagnosis-dependent
Source: Virtual Congress 2020 – Diagnostic and prognostic markers for disease-associated interstitial lung disease and hypersensitivity pneumonitis
Year: 2020
The efficacy of a walk-bike on quality of life and exercise capacity in patients with idiopathic pulmonary fibrosis (IPF). A pilot study
Source: International Congress 2015 – IPF: clinical aspects
Year: 2015
Evaluation of the COPD assessment test (CAT) for measuring health-related quality of life in patients with interstitial lung disease
Source: Annual Congress 2011 - Clinical perspectives in several interstitial diseases
Year: 2011
Pulmonary rehabilitation outcome: quality of life (QoL) and COPD severity
Source: Eur Respir J 2004; 24: Suppl. 48, 633s
Year: 2004
The King’s brief interstitial lung disease (K-BILD) questionnaire; an updated minimal important difference
Source: International Congress 2016 – Clinical aspects of ILD
Year: 2016
Symptoms and quality of life in relation to lung function and comorbidities in patients with idiopathic pulmonary fibrosis: INSIGHTS-IPF registry
Source: International Congress 2016 – IPF clinical
Year: 2016
A comparison of two scoring methods for the King’s brief interstitial lung disease questionnaire
Source: International Congress 2015 – Sarcoidosis: clinical
Year: 2015
Quality of life measures in patients with idiopathic pulmonary fibrosis
Source: Annual Congress 2013 –Idiopathic pulmonary fibrosis: clinical view
Year: 2013
Effect of nintedanib on cough and health related quality of life in patients with idiopathic pulmonary fibrosis
Source: International Congress 2016 – IPF: from pathogenesis to treatment I
Year: 2016
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept